Document Type : Short Communication


1 International Center for Neurologycal Restoration

2 medicine

3 Medicine

4 University of Medical Sciences ‟Dr. Zoilo E. Marinello Vidaurreta”. Las Tunas, Cuba.

5 National Center of Toxicology. La Havana, Cuba.

6 Instituto Cardeal Dom Alexamdre do Nascimento. Malanje. Angola


Background: Humans are very susceptible to the poison of insects. Some animals can produce substances that cause allergic reactions in humans. In these conditions, the immune system responds through mechanisms that provoke a state of defense in the affected person to fight against the aggression. In many cases, this defense is very strong to the organism itself.
Methods: The topic: “hypersensitivity due to stings of insects (bees and wasps)” was reviewed by keywords of articles included in the Google Scholar, Web of Science, and PubMed databases. The articles were selected by their relevance. Recently published articles in peer-reviewed journals were included, conducting a detailed review of all contents.
Results: The review indicated that the hypersensitivity mechanisms produced by bee and wasp stings are mainly mediated by IgE’s antibodies. In addition, the crucial importance of a rapid response to the first symptoms of hypersensitivity to prevent the venom severe symptoms leading to the patient´s death is emphasized.
Conclusions: The current knowledge of hypersensitivity reactions in individuals susceptible to bee and wasp stings was reviewed and summarized, revealing that IgE-mediated allergic reactions are the main mechanism. Adequate treatment after the inoculation of the poison is decisive in the patient´s recovery.


  1. Hemmer W, Wantke F. Insect hypersensitivity beyond bee and wasp venom allergy. Allergol Select. 2020;30(4):97-104. doi:10.5414/ALX02123E.
  2. Turillazzi S, Turillazzi F. Climate changes and Hymenoptera venom allergy: are there some connections?. Curr Opin Allergy Clin Immunol. 2017;17(5):344-9.
  3. Lee H, Halverson S, Mackey R. Insect Allergy. Prim Care 2016;43(3):417-31. doi: 10.1016/j.pop.2016.04.010. PMID: 27545732.
  4. Abrams EM, Golden DBK. Approach to Patients with Stinging Insect Allergy. Med Clin North Am. 2020;104(1):129-43.
  5. Bilò MB, Martini M, Tontini C, Corsi A, Antonicelli L. Anaphylaxis. Eur Ann Allergy Clin Immunol. 2021;53(1):4-17. doi:10.23822/EurAnnACI.1764-1489.158.
  6. Hockenhull J, Elremeli M, Cherry MG, Mahon J, Lai M, Darroch J, Oyee J, Boland A, Dickson R, Dundar Y, Boyle R. A systematic review of the clinical effectiveness and cost- effectiveness of Pharmalgen® for the treatment of bee and wasp venom allergy. Health   Technol Assess. 2012;6(12):1-110. doi: 10.3310/hta16120. PMID: 22409877;   PMCID: PMC4781549.
  7. Dispenza MC. Classification of hypersensitivity reactions. Allergy Asthma Proc. 2019 1;40(6):470-3.
  8. Adib-Tezer H, Bayerl C. Honeybee and wasp venom allergy: Sensitization and immunotherapy. J Dtsch Dermatol Ges. 2018;16(10):1228-1247. doi: 10.1111/ddg.13670. PMID: 30300499.
  9. Amaruddin AI, Koopman JPR, Muhammad M, Versteeg SA, Wahyuni S, van Ree R, Yazdanbakhsh M, Hamid F, Sartono E. Bee- and Wasp-Venom Sensitization in Schoolchildren of High- and Low-Socioeconomic Status Living in an Urban Area of Indonesia. Int Arch Allergy Immunol. 2021;182(11):1036-1045. doi: 10.1159/000516155. Epub 2021 May 5. PMID: 33951631; PMCID: PMC8686719.
  10. Reber LL, Hernandez JD, Galli SJ. The pathophysiology of anaphylaxis. J Allergy Clin Immunol. 2017;140(2):335-48.
  11. Shaker MS, Hsu D, Gruenberg DA. An update on venom allergy. Curr Opin Pediatr. 2013;25(5):629-34.
  12. Akdis CA, Arkwright PD, Brüggen MC, Busse W, Gadina M, Guttman-Yassky E, Kabashima K, Mitamura Y, Vian L, Wu J, Palomares O. Type 2 immunity in the skin and lungs. Allergy. 2020;75(7):1582-1605. doi: 10.1111/all.14318. Epub 2020 May 10. PMID: 32319104.
  13. Zhu J. T helper 2 (Th2) cell differentiation, type 2 innate lymphoid cell (ILC2) development and regulation of interleukin-4 (IL-4) and IL-13 production. Cytokine. 2015;75(1):14-24.
  14. Kubo M. Innate and adaptive type 2 immunity in lung allergic inflammation. Immunol Rev. 2017;278(1):162-72.
  15. Zeng WP. 'All things considered': transcriptional regulation of T helper type 2 cell differentiation from precursor to effector activation. Immunology. 2013;140(1):31-8.
  16. Singh S, Mann BK. Insect bite reactions. Indian J Dermatol Venereol Leprol. 2013;79(2):151-64.
  17. Stone KD, Prussin C, Metcalfe DD. IgE, mast cells, basophils, and eosinophils. J Allergy Clin Immunol. 2010;125(2):73-80. doi: 10.1016/j.jaci.2009.11.017. PMID: 20176269; PMCID: PMC2847274.
  18. Warrell DA. Venomous Bites, Stings, and Poisoning: An Update. Infect Dis Clin North Am. 2019;33(1):17-38.
  19. Folci M, Ramponi G, Arcari I, Zumbo A, Brunetta E. Eosinophils as Major Player in Type 2 Inflammation: Autoimmunity and Beyond. Adv Exp Med Biol. 2021;1347:197-219. doi: 10.1007/5584_2021_640.:197-219.
  20. 2016;50(2):189-213.
  21. Sirithep, U., Chinaroonchai, K. Rhabdomyolysis and Acute Respiratory Distress Syndrome Secondary to Multiple Wasp Stings. Asia Pacific Journal of Medical Toxicology. 2017; 6(4):132-135. doi: 10.22038/apjmt.2017.10090
  22. Chowdhury, F., Bari, M., Shafi, A., Ruhan, A., Hossain, M., Chowdhury, S., Hafiz, M. Acute Kidney Injury Following Rhabdomyolysis due to Multiple Wasp Stings (Vespa affinis). Asia Pacific Journal of Medical Toxicology. 2014;3(1):41-43. doi: 10.22038/apjmt.2014.2470
  23. Labella M, Garcia-Neuer M, Castells M. Application of precision medicine to the treatment of anaphylaxis. Curr Opin Allergy Clin Immunol.2018;18(3):190-7.
  24. Navalpakam A, Thanaputkaiporn N, Poowuttikul P. Management of Anaphylaxis. Immunol Allergy Clin North Am. 2022;42(1):65-76.
  25. Ochfeld EN, Greenberger PA. Stinging insect allergy and venom immunotherapy. Allergy Asthma Proc. 2019;40(6):372-5.
  26. Pflipsen MC, Vega Colon KM. Anaphylaxis: Recognition and Management. Am Fam Physician. 2020;102(6):355-62.
  27. Ruiz OA, Mikkelsen S, Bindslev-Jensen C, Mortz CG. Pre-hospital treatment of bee and wasp induced anaphylactic reactions: a retrospective study. Scand. J. Trauma, Resusc. Emerg. Med. 2017;25:(4):1757-7241. doi: 10.1186/s13049-016-0344-y.
  28. George J, Malik R, Gogna A. Hypersensitivity Reaction and Acute Respiratory Distress Syndrome in Pyrethroid Poisoning and Role of Steroid Therapy. Asia Pacific Journal of Medical Toxicology. 2015; 4(2): 91-93. doi: 10.22038/apjmt.2015.3732
  29. Zappia CD, Monczor F. Therapeutic utility of glucocorticoids and antihistamines cotreatment. Rationale and perspectives. Pharmacol Res Perspect. 2019;7(6):e00530. doi: 10.1002/prp2.530. PMID: 31859461; PMCID: PMC6923805.
  30. Richards JB, Wilcox SR. Diagnosis and management of shock in the emergency department. Emerg Med Pract. 2014;16(3):1-22.
  31. Working Group of the Resuscitation Council (UK) Emergency Treatment of Anaphylactic Reactions. Guidelines for Healthcare Providers. London: Resuscitation Council (UK); 2008. [Accessed March 10, 2015]. Available from:
  32. Holgate ST. Cytokine and anti-cytokine therapy for the treatment of asthma and allergic disease. Cytokine. 2004;28(4-5):152-7. doi: 10.1016/j.cyto.2004.07.010. PMID: 15588688.
  33. Poole JA, Meng J, Reff M, Spellman MC, Rosenwasser LJ. Anti-CD23 monoclonal antibody, lumiliximab, inhibited allergen-induced responses in antigen-presenting cells and T cells from atopic subjects. J Allergy Clin Immunol. 2005;116(4):780-8. doi: 10.1016/j.jaci.2005.07.007. PMID: 16210051.
  34. Radonjic-Hoesli S, Pavlov N, Simon HU, Simon D. Are blood cytokines reliable biomarkers of allergic disease diagnosis and treatment responses?. Journal of allergy and clinical immunology. 2022;150(2): 251-258.